Discover 1,022 paid clinical trials in Stamford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,022
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
for
Advanced Solid Tumors
Location: New Haven CT, Hinsdale IL, Houston TX, Scottsdale AZ,
Sponsor: Sun Pharma Advanced Research Company Limited
Sex: All
Age: 18+
Code: NCT07042100
Phase1, Recruiting
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors, Advanced Breast Cancer
Location: New Haven CT, Boston MA, Fairfax VA, Huntersville NC,
Sponsor: Ensem Therapeutics
Sex: All
Age: 18+
Code: NCT06993844
Phase1, Phase2, Recruiting
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
for
CTCL
Location: New Haven CT, Boston MA, Rochester NY, Richmond VA,
Sponsor: Prescient Therapeutics, Ltd.
Sex: All
Age: 18+
Code: NCT06854653
Phase2, Recruiting
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
for
Familial Adenomatous Polyposis (FAP)
Location: New Haven CT, Boston MA, Danville PA, Baltimore MD,
Sponsor: Rapamycin Holdings Inc.
Sex: All
Age: 18+
Code: NCT06950385
Phase3, Recruiting
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: New Haven CT, Boston MA, Fairfax VA, Pittsburgh PA,
Sponsor: NiKang Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07029399
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
for
Metastatic Castration-resistant Prostate Cancer
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT06100705
Phase2, Recruiting
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New Haven CT, Madison WI, Houston TX, Seattle WA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06625593
Phase1, Recruiting
Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors
for
Advanced Refractory Solid Tumors,
Location: New Haven CT, Ohio City OH, Michigan Center MI,
Sponsor: Cosmo Technologies Ltd
Sex: All
Age: 18+
Code: NCT03863145
Early_phase1, Recruiting
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
for
Neoplasm, Cancer, Malignant Tumors
Location: New Haven CT, Boston MA, Fairfax VA, Grand Rapids MI,
Sponsor: Compugen Ltd
Sex: All
Age: 18+
Code: NCT06759649
Phase1, Recruiting
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
for
Cancer, Cancer Central Nervous System, Cancer Thoracic,
Location: New Haven CT, Pittsburgh PA, Dallas TX, Duarte CA,
Sponsor: RefleXion Medical
Sex: All
Age: 0+
Code: NCT05406167
Recruiting
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: New Haven CT, New Brunswick NJ, Boston MA, Baltimore MD,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06385080
Phase1, Phase2, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Haven CT, New Brunswick NJ, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase3, Recruiting
Adaptation and Implementation of Peer Support in Brazil
for
Peer Support
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05842889
Recruiting
New
A Study to Learn About the Single Dose Pharmacokinetics of Study Medicine Called Tilrekimig in Healthy Adults When Co-Mixed With rHuPH20
for
Healthy
Location: New Haven CT
Sponsor: Pfizer
Sex: All
Age: 18 - 65
Code: NCT07792941
Phase1, Recruiting
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: New Haven CT, Boston MA, Baltimore MD, Fairfax VA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05061550
Phase2, Recruiting
A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With a KRAS p.G12D Mutation.
for
KRAS P.G12D
Location: New Haven CT, Houston TX, San Antonio TX
Sponsor: D3 Bio (Wuxi) Co., Ltd
Sex: All
Age: 18+
Code: NCT07456046
Phase1, Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
for
Breast Cancer, Locally Advanced Breast Cancer,
Location: New Haven CT, Burlington MA, Sayre PA, Annapolis MD,
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07085767
Phase3, Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: New Haven CT, New York NY, New Brunswick NJ, Boston MA,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07011719
Phase3, Recruiting
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma